Utility of Clinical–Radiomic Model to Identify Clinically Significant Prostate Cancer in Biparametric MRI PI-RADS V2.1 Category 3 Lesions

MLA

Pengfei Jin, et al. “Utility of Clinical–Radiomic Model to Identify Clinically Significant Prostate Cancer in Biparametric MRI PI-RADS V2.1 Category 3 Lesions.” Frontiers in Oncology, vol. 12, Feb. 2022. EBSCOhost, https://doi.org/10.3389/fonc.2022.840786.

APA

Pengfei Jin, Liqin Yang, Xiaomeng Qiao, Chunhong Hu, Chenhan Hu, Ximing Wang, & Jie Bao. (2022). Utility of Clinical–Radiomic Model to Identify Clinically Significant Prostate Cancer in Biparametric MRI PI-RADS V2.1 Category 3 Lesions. Frontiers in Oncology, 12. https://doi.org/10.3389/fonc.2022.840786

Chicago

Pengfei Jin, Liqin Yang, Xiaomeng Qiao, Chunhong Hu, Chenhan Hu, Ximing Wang, and Jie Bao. 2022. “Utility of Clinical–Radiomic Model to Identify Clinically Significant Prostate Cancer in Biparametric MRI PI-RADS V2.1 Category 3 Lesions.” Frontiers in Oncology 12 (February). doi:10.3389/fonc.2022.840786.